Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04742075 |
| Title | Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer (DOVACC) |
| Acronym | DOVACC |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DNK |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rigshospitalet | RECRUITING | København Ø | Sjaelland | 2100 | Denmark | Details |